Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 15, 2012, Pages 2111-2118

  Taneja, Charu ^a   Juday, Timothy ^b   Gertzog, Larry ^a   Edelsberg, John ^a   Correll, Todd ^b   Hebden, Tony ^b   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Adherence; HIV; Non nucleoside reverse transcriptase inhibitor; Persistence

Indexed keywords

EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR; EMTRICITABINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; COMBINATION ANTIRETROVIRAL THERAPY; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE INHIBITORS; YOUNG ADULT;

EID: 84866490133     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.719875     Document Type: Article

References (16)

1. d'Arminio Monforte A, Lepri AC, Rezza G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. study group. Italian cohort of antiretroviral-naive patients. AIDS 2000;14(5):499-507 (Pubitemid 30209692)
2. Mocroft A, Youle M, Moore A, et al. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS 2001;15(2):185-94 (Pubitemid 32142293)
3. Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. CID 2005;40:158-63 (Pubitemid 40053474)
4. Osterberg L, Blaschkle T. Adherence to medication. N Engl J Med 2005;353:487-97 (Pubitemid 41127293)
5. Cambiano V, Lampe F, Rodger A, et al. Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS 2010;24(8):1153-61
6. Bae J, Guyer W, Grimm K, et al. Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical car and research. AIDS 2011;25:29-290
7. Tam L, Chui C, Brumme C, et al. The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug class. J Acquir Immune Defic Syndr 2008;49(3):266-71
8. Martin M, Cacho E, Codina M, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA Viral Load: a prospective Cohort Study. AIDS Res Hum Retroviruses 2008;24(10):1263-8
9. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008;31:213-24
10. Parienti JJ, Bangsberg DR, Verdon R, et al. Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis 2009;48(4):484-8
11. Juday T, Gupta S, Grimm K, et al. Factors associated with complete adherence to HIV combination antiretroviral therapy. HIV Clin Trials 2011;12(2):71-8
12. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83 (Pubitemid 17055592)
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
14. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 1-167. Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf [Last accessed November 1] [2011]
15. Bangsberg DR, Ragland K, Monk A, et al. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS 2010;24:2835-40
16. Machtinger E, Bangsberg D. Adherence to antiretroviral therapy. Available from: http://hivinsite.ucsf.edu/InSite?page=kb- 03-02-09 [Last accessed October 20] [2011]